JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB266808

Human MEA1 knockout HEK-293T cell line

Be the first to review this product! Submit a review

|

(0 Publication)

MEA1 KO cell line available to order. KO validated. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, 10 bp deletion in exon 2 and 14 bp insertion in exon 2. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.

View Alternative Names

HYS, MEA, MEA1_HUMAN, Male enhanced antigen (H Y structural gene), Male-enhanced antigen 1

2 Images
Sanger Sequencing - Human MEA1 knockout HEK-293T cell line (AB266808)
  • Sanger seq

Unknown

Sanger Sequencing - Human MEA1 knockout HEK-293T cell line (AB266808)

Allele-2 : 14 bp insertion in exon 2.

Sanger Sequencing - Human MEA1 knockout HEK-293T cell line (AB266808)
  • Sanger seq

Unknown

Sanger Sequencing - Human MEA1 knockout HEK-293T cell line (AB266808)

Allele-1 : 10 bp deletion in exon 2

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 10 bp deletion in exon 2 and 14 bp insertion in exon 2

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab266808-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266808 Human MEA1 knockout HEK-293T cell line", "number":"AB266808-CMP01" }, { "size":"1 x 1000000 Cells/vial", "name":"ab255449 Human wild-type HEK-293T cell line", "number":"AB266808-CMP02" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab266808-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255449 Human wild-type HEK-293T cell line", "number":"AB266808-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab266808 Human MEA1 knockout HEK-293T cell line", "number":"AB266808-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266808-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266808 Human MEA1 knockout HEK-293T cell line", "number":"AB266808-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266808-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266808 Human MEA1 knockout HEK-293T cell line", "number":"AB266808-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
MEA1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

MEA1 also known as Male-enhanced antigen 1 is a protein that plays a significant role in the process of spermatogenesis. It is a protein composed of approximately 65 kDa. MEA1 is predominantly expressed in the testes indicating its involvement in male reproductive function. The protein has been identified to participate in cellular processes essential to germ cell development and its expression pattern suggests it may have functions that are testis-specific or testis-enhanced.
Biological function summary

MEA1 interacts with cellular machinery involved in cell cycle regulation and differentiation. Its role has been observed in the development of male germ cells. MEA1 does not form part of a larger protein complex; instead it functions as an independent entity that supports spermatid differentiation. It seems essential for proper morphological changes necessary for mature sperm formation.

Pathways

Studies show that MEA1 is integral to pathways guiding spermatogenesis and germ cell maturation. It does not directly link to more widespread signaling routes like MAPK or PI3K. MEA1 may interact with proteins such as CREM a transcription factor that regulates genes critical for sperm cell development suggesting it integrates into the transcriptional regulatory framework essential for efficient sperm production.

MEA1's aberrant expression is associated with male infertility specifically non-obstructive azoospermia which is a condition requiring intervention for sperm production failures. Connections to infertility emphasize the protein's role in maintaining healthy sperm production. Another protein associated with male infertility is DAZL which MEA1 could potentially interact with given their shared involvement in spermatogenesis. Further research could elucidate MEA1's exact interactions and pathogenic roles connected to reproductive issues.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com